Ceapro

Natural Bio-active Cosmetic Ingredientsceapro.com

Ceapro Inc. is a Canadian biotech company that develops and supplies proprietary oat-derived bioactive ingredients — including avenanthramides, beta-glucans, oat flour, and oat oil — to global cosmetics, personal care, nutraceutical, and pharmaceutical manufacturers from its GMP facility in Edmonton.

Company typePublic
Founded1994
HeadquartersEdmonton, Canada
Headcount11–50
GTM typeB2B
OfferingHardware or Manufacturing

What Ceapro does

Ceapro Inc. is a Canadian biotechnology company founded in 1994 and headquartered in Edmonton, Alberta, that develops and manufactures premium, science-backed bioactive ingredients derived primarily from oats for the cosmetics, personal care, nutraceutical, and pharmaceutical industries. Its product portfolio consists of four core ingredients — CP Oat Avenanthramide Extract (anti-irritant/antioxidant), CP Oat Beta Glucan (moisturizing, skin-repairing, GRAS-approved for nutraceuticals), CP Oat Flour Superfine/Colloidal Oatmeal, and Oat Oil (barrier restoration) — all produced from elite North American oat varieties under exclusive supply arrangements that provide complete farm-to-finished-extract traceability.

The company's technical platform rests on three proprietary processes: ethanol fractionation, chromatography purification, and Pressurized Gas Expanded (PGX) technology, all operated within a 30,000 sq. ft. GMP-certified bio-processing facility that integrates R&D, pilot, and commercial-scale production. Certifications include EcoCert, Non-GMO, Gluten-Free, Allergen-Free, Fragrance-Free, and Not-Tested-on-Animals, which together support premium positioning with global cosmetics megabrands. Ceapro is extending PGX into pharmaceutical-grade applications, notably yeast beta glucan for immune-boosting clinical trials, funded in part by Canadian federal grants.

Commercially, Ceapro operates a B2B ingredients model with quote-based pricing, direct enterprise sales to global megabrands, and a website-driven sample-request funnel as the primary lead capture mechanism. The company is publicly traded (OTCMKTS: CRPOF; CVE: CZO) and operates as a subsidiary of Cosciens Biopharma. Revenue is concentrated in the single-digit millions (~$7M in 2023), the company is currently unprofitable with a –69.6% net margin, and the customer base is qualitatively described as "global megabrands" without disclosed specific logos.

Ceapro firmographics

Firmographics

Name: Ceapro
Legal name: Ceapro Inc.
Website: https://ceapro.com
Company type: Public
Founded year: 1994
Operating status: Operating
Headcount range: 11–50 employees
Short description: Ceapro Inc. is a Canadian biotech company that develops and supplies proprietary oat-derived bioactive ingredients — including avenanthramides, beta-glucans, oat flour, and oat oil — to global cosmetics, personal care, nutraceutical, and pharmaceutical manufacturers from its GMP facility in Edmonton.
Ownership category
akta.pro rank

Ceapro industry classification

Industry

Product category: Natural Bio-active Cosmetic Ingredients
NAICS: Fruit and Vegetable Preserving and Specialty Food Manufacturing (3114), Starch and Vegetable Fats and Oils Manufacturing (31122)
SIC: Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry: Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM)

Keywords

Oat-derived bioactives
Cosmetic ingredients
Skincare formulations
Nutraceutical ingredients
Natural personal care

Where Ceapro is headquartered

Location

Headquarters

HQ city: Edmonton
HQ country: Canada
HQ region: North America

Offices1 record

Markets served

Ceapro business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

Oat-derived Bio-active Ingredients: Sale of proprietary oat-derived bio-active ingredients including CP Oat Avenanthramide Extract, CP Oat Beta Glucan, CP Oat Flour Superfine, and Oat Oil to cosmetics, personal care, and nutraceutical manufacturers. Revenue is generated through product sales with pricing based on volume and specification requirements.
Pharmaceutical Ingredients: Development of pharmaceutical-grade active pharmaceutical ingredients (APIs) including yeast beta glucan for clinical trials related to immune-boosting and COVID-19 conditions through their PGX technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Ceapro product offering

Product offering

Core offering

Ceapro Inc. develops and manufactures premium, science-backed natural bio-active ingredients derived from oats (Avena sativa), including avenanthramide extract, beta glucan, colloidal oatmeal, and oat oil. These ingredients are produced using proprietary green bioprocessing technologies at a 30,000 sq. ft. GMP-certified facility in Edmonton, Alberta, and are supplied to cosmetics, personal care, nutraceutical, and pharmaceutical manufacturers worldwide.

Product overview

Ceapro is a Canadian biotech company that develops and manufactures premium, science-backed natural oat-derived bioactive ingredients for the cosmetics, personal care, and nutraceutical industries. The product portfolio consists of four core products: CP Oat Avenanthramide Extract (anti-irritant and antioxidant), CP Oat Beta Glucan (moisturizing and skin-repairing, GRAS approved for nutraceuticals), CP Oat Flour Superfine/Colloidal Oatmeal (exfoliation and soothing), and Oat Oil (skin barrier restoration and nourishment). These ingredients are produced using proprietary extraction and processing technologies including Ethanol Fractionation Processes, Chromatography Purification, and Pressurized Gas Expanded (PGX) technology, all manufactured in the company's GMP-certified facility.

Differentiator

Problem solved

Functional benefit

Products and services

CP Oat Avenanthramide Extract

Quantifiable outcome

30+ years of continuous operation and research in oat-derived ingredients
+1 more outcomes

Companies that use Ceapro

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Ceapro technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ceapro partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Ceapro competitors and assessment

Company assessment

Broad incumbents

dsm-firmenich: Global specialty ingredients major formed by the merger of DSM and Firmenich, with a large Personal Care & Aroma and Nutrition segments. Directly comparable to Ceapro as a B2B supplier of scientifically validated bioactive ingredients to cosmetics, personal care, and nutraceutical megabrands, though vastly larger in scale and breadth.
BASF Care Creations: BASF's personal care specialty ingredients arm supplies bioactives, emollients, and actives to global cosmetic brands. Overlaps directly with Ceapro's ingredient portfolio (oat-derived emollients and bioactives), but as part of a much broader chemicals and ingredients conglomerate.

Direct peers

Evonik Personal Care: Specialty silica, ceramide, and bioactive specialty ingredients for skin and hair care. Direct competitor in the cosmetic actives space with comparable scientific positioning and B2B sales motion into the same global megabrands Ceapro serves.
Givaudan Active Beauty: Givaudan's Active Beauty business supplies cosmetic bioactive ingredients (antioxidants, skin-conditioning actives) to global personal care brands. Closely comparable to Ceapro's positioning in science-backed, naturally sourced cosmetic actives, though Givaudan offers a much broader portfolio and global service network.

Peers

Symrise (Cosmetic Ingredients):

Market position

Strengths2 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Ceapro compliance and trust

Trust signal

Compliance5 records

Ceapro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ceapro leadership team

Management profile

Number of profiles

Profiles5 records

Ceapro funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ceapro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ceapro

What does Ceapro do?

Is Ceapro a public or private company?

Ceapro is a public company. It is classified as public and is currently operating.

When was Ceapro founded?

Ceapro was founded in 1994. It employs 11 to 50 people.

Where is Ceapro based?

Ceapro is headquartered in Edmonton, Canada, in the North America region.

How does Ceapro make money?

Two revenue lines are on record. Oat-derived Bio-active Ingredients are the primary driver. The others are pharmaceutical Ingredients.

Who are Ceapro's main competitors?

Broad incumbents on record are dsm-firmenich and BASF Care Creations. Direct peers are Evonik Personal Care and Givaudan Active Beauty. Symrise (Cosmetic Ingredients) is listed as a peer.

Does Ceapro have an API?

No public API is recorded for Ceapro.

What industry is Ceapro in?

Ceapro's product category is Natural Bio-active Cosmetic Ingredients. Its primary akta.pro industry code is CRADAOAM, Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes). Its NAICS code is 3114 and its SIC code is 2833.